Pharmacokinetics of linagliptin in subjects with hepatic impairment

2012

AIM To investigate whether hepatic impairment affects linagliptin pharmacokinetics, pharmacodynamics and tolerability.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

21

References

55

Citations